Trending

WHO Releases First Guidelines for Adult Type 1 Diabetes Management

Geneva:More than a century after the discovery of insulin, many individuals with type 1 diabetes still face challenges accessing necessary insulin and care. Type 1 diabetes is a chronic condition where the body fails to produce sufficient insulin, requiring those affected to rely on daily insulin intake for survival.

According to Emirates News Agency, in conjunction with World Diabetes Day 2026 on November 14, the World Health Organization (WHO) has introduced its inaugural guidelines for diagnosing and managing type 1 diabetes in adults. These guidelines are intended to be applicable in all environments, including those with limited resources, as well as emergency and humanitarian contexts.

In 2025, approximately 9.5 million individuals globally were living with type 1 diabetes, with an additional 500,000 diagnoses occurring within that year. Although type 1 diabetes is commonly associated with childhood, it is increasingly prevalent among adults. Dr. Søren Brostrøm, WHO Director of Noncommunicable Diseases and Mental Health, emphasized the critical need for accessible, affordable, and high-quality insulin. The WHO guidelines offer evidence-based recommendations aimed at optimizing care delivery, especially in resource-constrained and disrupted health service settings.

The new guidelines recommend that individuals with type 1 diabetes administer insulin injections multiple times daily, with dosage adjustments based on blood glucose levels. Human insulin, which mimics the body's natural insulin, is highlighted as an effective treatment option, with other insulin types available when necessary.

Regular blood glucose monitoring is advised, utilizing methods such as regular blood tests, finger prick tests, or continuous glucose monitors. In situations where blood glucose testing is unavailable, urine glucose testing is suggested as an alternative.

These guidelines align with WHO's objectives to ensure universal access to affordable insulin and self-monitoring of blood glucose for all type 1 diabetes patients by 2030. WHO plans to assist countries in implementing these recommendations by offering practical tools and guidance, and encourages the involvement of individuals with type 1 diabetes in the development and evaluation of diabetes programs.

World Diabetes Day 2026 emphasizes 'Early action on diabetes,' highlighting the severe complications diabetes can cause, such as blindness, kidney failure, and cardiovascular issues. The global prevalence of diabetes has surged more than fourfold since 1990, with 830 million people living with diabetes in 2022, predominantly type 2 diabetes. Alarmingly, over 40% of individuals with diabetes remain undiagnosed.

Recent Post

Advertisement